David Kramer: The first US production in 30 years of molybdenum-99, the parent isotope of the most widely used medical radioisotope, is expected to begin within weeks after federal regulators approved a manufacturing process developed by Wisconsin-based NorthStar Medical Radioisotopes. NorthStar received $25 million in matching funds from DOE for development of the neutron capture process and $14.8 million of an expected $25 million total for its accelerator approach.
Latest from John Shanahan
- Radioactive waste stranded as U.S. shifts from nuclear (Jeff Johnson) USofA
- The case for advanced nuclear reactors (Lisa Murkowski, Washington Examiner) USofA
- Extremwerte Das Klima unter Generalverdacht (ZAMG, Sebastian Luening, Kalte Sonne) Austria German Deutsch
- Inconvenient Truths About Renewables (Clinton Crackel) USofA
- Acorn Creek Trail, Summit County, Colorado (John Shanahan) USofA